These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6433476)

  • 1. Financial aspects of hemophilia care.
    Carman CJ; Britten AF; Ala F; Smit Sibinga C
    Scand J Haematol Suppl; 1984; 40():529-33. PubMed ID: 6433476
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant clotting factors in the treatment of hemophilia.
    Lee C
    Thromb Haemost; 1999 Aug; 82(2):516-24. PubMed ID: 10605745
    [No Abstract]   [Full Text] [Related]  

  • 3. Factor VIII: maximal benefit?
    Nour-Eldin F
    Eur J Med; 1992 Apr; 1(1):55-7. PubMed ID: 1341979
    [No Abstract]   [Full Text] [Related]  

  • 4. High potency factor VIII concentrates: value not proved?
    Cash JD
    BMJ; 1991 Sep; 303(6803):633-4. PubMed ID: 1932909
    [No Abstract]   [Full Text] [Related]  

  • 5. [Consensus hemophilia treatment].
    Briët E; Breederveld C
    Ned Tijdschr Geneeskd; 1987 Oct; 131(43):1914-6. PubMed ID: 3120016
    [No Abstract]   [Full Text] [Related]  

  • 6. The economics of immune tolerance and treatment of hemophiliacs with inhibitors.
    Kessler CM; Aledort LM
    Vox Sang; 1996; 70 Suppl 1():74-6. PubMed ID: 8869476
    [No Abstract]   [Full Text] [Related]  

  • 7. Ricky Ray Hemophilia Relief Fund Program. Adoption of interim final rule as final rule with amendments.
    Health Resources and Services Administration, HHS
    Fed Regist; 2001 Nov; 66(226):58667-72. PubMed ID: 11780623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modern substitution therapy does not just lengthen the lives of hemophiliacs].
    Koller F
    Ther Umsch; 1979 Apr; 36(4):291-3. PubMed ID: 451947
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness--can it be measured?
    Bohn RL; Avorn J
    Semin Hematol; 1993 Jul; 30(3 Suppl 2):20-3. PubMed ID: 8367739
    [No Abstract]   [Full Text] [Related]  

  • 10. Factor VIII usage in the Wisconsin Hemophilia Program; factor VIII usage in hemophilia.
    Lange D; Lazerson J
    Wis Med J; 1982 Feb; 81(2):28-31. PubMed ID: 6803446
    [No Abstract]   [Full Text] [Related]  

  • 11. Health status in Iranian haemophilic patients.
    Karimi M; Rahmani S; Ardeshiri R; Pasalar M
    Haemophilia; 2008 May; 14(3):615-7. PubMed ID: 18393983
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylactic factor replacement in hemophilia.
    Carcao MD; Aledort L
    Blood Rev; 2004 Jun; 18(2):101-13. PubMed ID: 15010149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Million dollar miracles.
    Smith SD
    Minn Med; 2006 Apr; 89(4):30-5, 51. PubMed ID: 16681280
    [No Abstract]   [Full Text] [Related]  

  • 14. German parliament investigates HIV infections.
    Karcher H
    BMJ; 1994 Nov; 309(6966):1389-90. PubMed ID: 7819839
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preparation and use of factor VIII concentrates in hemophilia].
    Vilar JM; Ortega F; Martin-Arias DM; Vazquez J; Navarro JL
    Sangre (Barc); 1969; 14(1):57-64. PubMed ID: 5792112
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor VIII inhibitor and severity of hemophilia.
    Schoppmann A; Waytes AT
    Thromb Haemost; 1996 Aug; 76(2):280-1. PubMed ID: 8865549
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibitors suppression in hemophilia A with continued treatment of factor VIII].
    Aznar JA; Jiménez C; García I; Martín G; Borrego D; Peiro A; Marty ML
    Sangre (Barc); 1982; 27(4A):572. PubMed ID: 6818701
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylactic use of factor VIII: an economic evaluation.
    Bohn RL; Avorn J; Glynn RJ; Choodnovskiy I; Haschemeyer R; Aledort LM
    Thromb Haemost; 1998 May; 79(5):932-7. PubMed ID: 9609224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostasis. II. The use of factor VIII concentrates in the therapy of hemophilia.
    Davis RB
    Nebr State Med J; 1971 Jun; 56(6):219-24. PubMed ID: 4253029
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant factor VIII in hemophilia.
    Cohen A; Butler R
    N Engl J Med; 1991 May; 324(21):1515-6. PubMed ID: 1902552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.